Breast Cancer Risk Assessment and Treatment


Personalized medicine is here. It's the responsibility of OB/GYNs, other women's health care clinicians, and primary care providers to understand how it can impact the decisions we and our patients make.

Read two case studies demonstrating the many ways in which genetic testing, breast cancer prognostic tests, and personalized medicine have improved the very foundation of patient care in this area.

Watch the associated video, below!

Learn How SNPs May Assist in Assessing Breast Cancer Risks for Your Patients



Related Videos
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit:
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit:
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit:
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit:
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit:
raanan meyer, md
New data shows elinzanetant's efficacy in treating menopausal symptoms | Image Credit:
Related Content
© 2024 MJH Life Sciences

All rights reserved.